Mannkind (MNKD) FCF Margin Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5,389.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,525.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -341.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 43,511.00 |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 231.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231.00 |
| Dec 31, 2025 | -2,573.00 |
| Sep 30, 2025 | 1,067.00 |
| Jun 30, 2025 | 1,007.00 |
| Mar 31, 2025 | -1,616.00 |
| Dec 31, 2024 | -1,964.00 |
| Sep 30, 2024 | -4,230.00 |
| Jun 30, 2024 | 4,161.00 |
| Mar 31, 2024 | 1,076.00 |
| Dec 31, 2023 | 6,210.00 |
| Sep 30, 2023 | 14,429.00 |
| Jun 30, 2023 | 967,456.00 |
| Mar 31, 2023 | 19,117.00 |
| Dec 31, 2022 | 3,495.00 |
| Sep 30, 2022 | 817.00 |
| Jun 30, 2022 | -962,298.00 |
| Mar 31, 2022 | -11,572.00 |
| Dec 31, 2021 | -5,719.00 |
| Sep 30, 2021 | -359.00 |
| Jun 30, 2021 | 188,298.00 |
| Mar 31, 2021 | -931.00 |
| Dec 31, 2020 | 4,528.00 |
| Sep 30, 2020 | 726,430.00 |
| Jun 30, 2020 | 814,850.00 |
| Mar 31, 2020 | -129.00 |
| Dec 31, 2019 | -20,257.00 |
| Sep 30, 2019 | -704,054.00 |
| Jun 30, 2019 | -942,709.00 |
| Mar 31, 2019 | 55,681.00 |
| Dec 31, 2018 | 81,771.00 |
| Sep 30, 2018 | 82,755.00 |
| Jun 30, 2018 | 22,881.00 |
| Mar 31, 2018 | -90,754.00 |
| Dec 31, 2017 | -55,903.00 |
| Sep 30, 2017 | -112,480.00 |